Literature DB >> 29509751

Going live: How microRNAs might bring living vaccines back into the fold.

Shraddha Chakradhar.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29509751     DOI： 10.1038/nm0318-248

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  9 in total

1.  PARALYTIC DISEASE ASSOCIATED WITH ORAL POLIO VACCINES.

Authors:  D A HENDERSON; J J WITTE; L MORRIS; A D LANGMUIR
Journal:  JAMA       Date:  1964-10-05       Impact factor: 56.272

2.  Engineering microRNA responsiveness to decrease virus pathogenicity.

Authors:  Elizabeth J Kelly; Elizabeth M Hadac; Suzanne Greiner; Stephen J Russell
Journal:  Nat Med       Date:  2008-10-26       Impact factor: 53.440

3.  MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice.

Authors:  Terza Brostoff; Patricia A Pesavento; Christopher M Barker; Joan L Kenney; Elizabeth A Dietrich; Nisha K Duggal; Angela M Bosco-Lauth; Aaron C Brault
Journal:  Vaccine       Date:  2016-09-13       Impact factor: 3.641

4.  MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.

Authors:  Louisa E Sjaastad; Jessica K Fiege; Barbara M Waring; Elizabeth J Fay; Ismarc Reyes; Branden Moriarity; Ryan A Langlois
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

5.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

6.  MicroRNA-mediated species-specific attenuation of influenza A virus.

Authors:  Jasmine T Perez; Alissa M Pham; Maria H Lorini; Mark A Chua; John Steel; Benjamin R tenOever
Journal:  Nat Biotechnol       Date:  2009-05-31       Impact factor: 54.908

7.  miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.

Authors:  Rasmus Møller; Toni M Schwarz; Vanessa M Noriega; Maryline Panis; David Sachs; Domenico Tortorella; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

8.  Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines.

Authors:  Dwight Barnes; Mark Kunitomi; Marco Vignuzzi; Kalle Saksela; Raul Andino
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

9.  Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.

Authors:  Alfred T Harding; Brook E Heaton; Rebekah E Dumm; Nicholas S Heaton
Journal:  mBio       Date:  2017-06-06       Impact factor: 7.867
  9 in total
  1 in total

1.  Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.

Authors:  Konstantin A Tsetsarkin; Olga A Maximova; Guangping Liu; Heather Kenney; Natalya L Teterina; Alexander G Pletnev
Journal:  mBio       Date:  2019-04-23       Impact factor: 7.867
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.